Sequence and structural determinants of efficacious de novo chimaeric antigen receptors.
PubMed / NCBI E-utilities · 学术索引收录 · 来源发布：Wed Sep 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收录：Thu Oct 08 2026 09:08:08 GMT+0000 (Coordinated Universal Time)
已保存的原文节选
Advances in generative protein design using artificial intelligence (AI) have enabled the rapid development of binders against heterogeneous targets, including tumour-associated antigens. Despite extensive biochemical characterization, these novel protein binders have had limited evaluation in candidate therapeutics, including chimaeric antigen receptor (CAR) T cells. Here we synthesize generative
以上为带出处的原文节选，完整内容请阅读原始链接。自动收录与主题分类不等于事实核验。